HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haralabos P Kalofonos Selected Research

Voltage-Gated Sodium Channels

10/2013Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
1/2009Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
6/2008A review on oxaliplatin-induced peripheral nerve damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haralabos P Kalofonos Research Topics

Disease

64Neoplasms (Cancer)
02/2024 - 02/2002
32Colorectal Neoplasms (Colorectal Cancer)
02/2022 - 02/2002
28Breast Neoplasms (Breast Cancer)
01/2023 - 03/2003
21Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 08/2005
11Neoplasm Metastasis (Metastasis)
10/2020 - 03/2003
10Disease Progression
12/2016 - 02/2002
9Glioma (Gliomas)
02/2019 - 02/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 05/2003
7Colonic Neoplasms (Colon Cancer)
04/2020 - 01/2007
5Adenocarcinoma
02/2022 - 03/2003
4Carcinoma (Carcinomatosis)
05/2019 - 06/2006
4Carcinogenesis
10/2011 - 03/2008
3Neuralgia (Stump Neuralgia)
02/2024 - 09/2008
3Lung Neoplasms (Lung Cancer)
07/2023 - 06/2008
3Cognitive Dysfunction
02/2022 - 07/2004
3Ovarian Neoplasms (Ovarian Cancer)
04/2020 - 10/2008
3Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 11/2007
3Necrosis
11/2013 - 12/2009
2Adenocarcinoma of Lung
08/2020 - 12/2016
2Glioblastoma (Glioblastoma Multiforme)
02/2019 - 01/2011
2Calcinosis
07/2011 - 11/2006
2Anemia
06/2008 - 06/2003
2Pain (Aches)
06/2008 - 04/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2008 - 04/2006
2Stomach Neoplasms (Stomach Cancer)
01/2007 - 01/2006
2Sarcoma (Soft Tissue Sarcoma)
06/2004 - 01/2004
1Inflammation (Inflammations)
10/2020
1Venous Thrombosis (Deep-Vein Thrombosis)
04/2020
1Venous Thromboembolism
04/2020

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
11/2022 - 10/2003
19Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 01/2005
14Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 07/2005
10Fluorouracil (Carac)FDA LinkGeneric
04/2020 - 02/2002
9Messenger RNA (mRNA)IBA
10/2019 - 09/2007
8ErbB Receptors (EGF Receptor)IBA
01/2018 - 11/2006
7Leucovorin (Folinic Acid)FDA Link
10/2013 - 02/2002
5Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2009
5PlatinumIBA
08/2020 - 07/2005
5Taxoids (Taxanes)IBA
01/2020 - 07/2005
5Trastuzumab (Herceptin)FDA Link
08/2019 - 05/2006
5Sunitinib (Sutent)FDA Link
02/2019 - 11/2007
5Carboplatin (JM8)FDA LinkGeneric
06/2010 - 12/2005
5Cisplatin (Platino)FDA LinkGeneric
10/2008 - 06/2004
4Hormones (Hormone)IBA
01/2023 - 03/2003
4Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2021 - 01/2008
4Estrogen ReceptorsIBA
08/2019 - 03/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 01/2009
4Capecitabine (Xeloda)FDA Link
10/2013 - 01/2005
4XELOXIBA
10/2013 - 01/2005
4Epirubicin (Ellence)FDA LinkGeneric
04/2012 - 01/2004
4Docetaxel (Taxotere)FDA Link
01/2012 - 01/2004
4AnthracyclinesIBA
01/2009 - 01/2007
3Tyrosine Kinase InhibitorsIBA
10/2021 - 05/2009
3Epidermal Growth Factor (EGF)IBA
01/2018 - 10/2015
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2016 - 01/2007
3Codon (Codons)IBA
01/2016 - 07/2010
3Bevacizumab (Avastin)FDA Link
04/2015 - 02/2010
3Platinum Compounds (Compounds, Platinum)IBA
01/2014 - 06/2008
3Voltage-Gated Sodium ChannelsIBA
10/2013 - 06/2008
3Matrix Metalloproteinases (MMPs)IBA
01/2013 - 03/2003
3Vitamin EFDA LinkGeneric
05/2011 - 09/2006
3Irinotecan (Camptosar)FDA LinkGeneric
01/2011 - 03/2003
3Lapatinib (GW572016)FDA Link
12/2010 - 05/2009
3liposomal doxorubicin (Doxil)FDA Link
01/2010 - 07/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2008 - 02/2002
2Protein Isoforms (Isoforms)IBA
07/2023 - 07/2012
2indolepropanol phosphate (IPP)IBA
07/2023 - 08/2020
2DNA (Deoxyribonucleic Acid)IBA
02/2022 - 12/2019
2Gefitinib (Iressa)FDA Link
10/2021 - 05/2009
2Transcription Factors (Transcription Factor)IBA
01/2021 - 10/2020
2RNA (Ribonucleic Acid)IBA
08/2020 - 07/2012
2integrin-linked kinaseIBA
08/2020 - 03/2018
2human ERBB2 proteinIBA
01/2020 - 08/2019
2taxaneIBA
01/2020 - 07/2005
2TamoxifenFDA LinkGeneric
08/2019 - 01/2013
2LigandsIBA
01/2018 - 07/2012
2ParaffinIBA
06/2015 - 07/2009
2Formaldehyde (Formol)FDA Link
06/2015 - 07/2009
2GemcitabineFDA Link
01/2015 - 07/2005
2Bortezomib (Velcade)FDA Link
09/2014 - 09/2008
2Phosphotransferases (Kinase)IBA
01/2014 - 11/2007
2Estrogens (Estrogen)FDA Link
11/2013 - 03/2003
2SurvivinIBA
08/2011 - 01/2010
2Metalloproteases (Metalloproteinases)IBA
01/2011 - 03/2003
2Prion ProteinsIBA
07/2010 - 03/2008
2Monoclonal AntibodiesIBA
05/2009 - 05/2009
1Small Interfering RNA (siRNA)IBA
07/2023
1TNF Receptor-Associated Factor 3IBA
11/2022
1RamucirumabIBA
02/2022
1CD40 AntigensIBA
01/2021
1Lymphotoxin beta ReceptorIBA
01/2021
1B-Cell Activation Factor ReceptorIBA
01/2021
1NivolumabIBA
01/2020
1LacosamideFDA Link
01/2020

Therapy/Procedure

46Drug Therapy (Chemotherapy)
02/2024 - 02/2002
20Therapeutics
01/2023 - 03/2003
5Adjuvant Chemotherapy
04/2020 - 03/2003
4Radiotherapy
02/2012 - 03/2003
2Craniotomy
05/2003 - 02/2002
1Precision Medicine
02/2022